Clinical Trial Update: Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating vitamin D to reduce oral mucosal inflammation in chemotherapy patients with oral squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucositis
• Oral Squamous Cell Carcinoma

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Oral Squamous Cell Carcinoma, Oral Mucositis | Phase 2, Phase 3 | Status: UNKNOWN